Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV

To the Editor In a recent cohort study, Aldred et al found that early tecovirimat treatment within 7 days of symptoms was associated with reduced progression of mpox disease in people with HIV. The authors recommend initiating early tecovirimat treatment for all patients with HIV and immunocompromised status or mucosal site involvement.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research